Paladin Labs Inc. / Distributor 6111 Royalmount Ave., Suite 102 Montreal, Quebec H4P 2T4
Marketing Authorization Holder
Paladin Labs Inc. 6111 Royalmount Ave., Suite 102 Montreal, Quebec H4P 2T4
Recalling Firm
Paladin Labs Inc. / Distributor
Capsules
DIN 00261432
100 mg
Introduction
Recalled products
NDarvon-N
Reason
Paladin has decided to recall all lots of NDarvon-N® (dextropropoxyphene, also known as propoxyphene) on the Canadian market and discontinue the sale of the product following the US FDA request for withdrawal of all propoxyphene containing products due to new data showing that the drug can cause serious toxicity to the heart, even when used at therapeutic doses. FDA concluded that the safety risks of propoxyphene products outweigh its benefits for pain relief at recommended doses.